428
Participants
Start Date
July 31, 2002
Primary Completion Date
October 31, 2003
Study Completion Date
October 31, 2003
PB127 for injectable suspension
0.175 mg/kg diluted in 150 mL Dextrose in Water 5% in glass bottles to be infused at 250 mL/hour until stead state achieve, 150 mL/hour during rest image acquisition, and 100-150 mL/hr during stress image acquistion. Single IV infusion, not to exceed 60 minutes.
St. Luke's Roosevelt Hospital Echocardiography Lab, New York
Mount Sinai Hospital, New York
University of Virginia Health System, Charlottesville
MidWest Cardiologist Research, Columbus
Krannert Institute of Cardiology, Indianapolis
Washington University School of Medicine, St Louis
Cardiovascular Consultants, Kansas City
The Center for Cardiovascular Studies Kramer & Crouse Cardiology, Shawnee Mission
Presbyterian Hospital of Dallas, Dallas
Methodist DeBakery Heart Center Cardiovascular Imaging Institute, Houston
Austin Heart, Austin
Heartcare, P.C., Scottsdale
Mayo Clinic Scottsdale, Scottsdale
University of California San Francisco, San Francisco
Stanford University Medical Center, Stanford
Endovascular Research, LLC, Eugene
Inland Cardiology, Spokane
Androscoggin Cardiovascular Associates, Auburn
Maine Cardiology Associates, South Portland
Lead Sponsor
Point Biomedical
INDUSTRY